Berman Capital Advisors’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
SCM
RIM
RCMC
MIP
RHJA
Berman Capital Advisors's IRMD Position: Q3 2021 in Review
Berman Capital Advisors held its iRadimed (IRMD) position steady in Q3 2021 at 41 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1890.
Berman Capital Advisors first reported a position in IRMD in Q2 2021 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold IRMD as of Q3 2021.
- Berman Capital Advisors held 41 shares of iRadimed worth $1K as of Q3 2021.
- Berman Capital Advisors left its iRadimed share count unchanged in Q3 2021.
- iRadimed made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1890 holding.
- Berman Capital Advisors first reported a position in iRadimed in Q2 2021 and has held it in 2 quarters since.
- 74 funds tracked by Wall St. Rank held iRadimed as of Q3 2021.
Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.